AMR Bio Overview
- Year Founded
-
2025
- Status
-
Private
- Latest Deal Type
-
2ndary - Private
- Investors
-
1
AMR Bio General Information
Description
Developer of anti infective pharmaceutical candidates intended for infection prevention. The company uses a proprietary ultra rapid antibacterial mechanism and supports preventative and dermal formulations, enabling healthcare providers to reduce post surgical staphylococcal infections and address antimicrobial resistance.
Contact Information
Website
www.amr-bio.comCorporate Office
- 25 Old Burlington Street
- Level 2
- London
- England, United Kingdom
Corporate Office
- 25 Old Burlington Street
- Level 2
- London
- England, United Kingdom
AMR Bio Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 2. Secondary Transaction - Private | Completed | Pre-Clinical Trials | ||||
| 1. Early Stage VC | 29-Sep-2025 | Completed | Pre-Clinical Trials |
AMR Bio Cap Table
| Stock | # of Shares Authorized |
Par Value | Dividend Rate (%) | Original Issue Price |
Liquidation | Liquidation Pref. Multiple |
Conversion Price | % Owned |
|---|---|---|---|---|---|---|---|---|
| Ordinary |
AMR Bio Patents
AMR Bio Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| US-9326511-B2 | Methods of inhibiting microbial biofilms | Active | 24-Oct-2008 | ||
| US-20110262511-A1 | Novel uses | Active | 24-Oct-2008 | ||
| US-20070167619-A1 | Novel uses of porphyrin compounds | Active | 23-Jun-2004 | ||
| US-7977474-B2 | Uses of porphyrin compounds | Active | 23-Jun-2004 | ||
| US-20070281915-A1 | Porphyrin derivatives and their use in photodynamic therapy | Active | 23-Dec-2002 | C07D487/22 |
AMR Bio Investors (1)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds |
|---|---|---|---|---|
| EMV Capital | Venture Capital | Minority |
AMR Bio FAQs
-
When was AMR Bio founded?
AMR Bio was founded in 2025.
-
Where is AMR Bio headquartered?
AMR Bio is headquartered in London, United Kingdom.
-
What industry is AMR Bio in?
AMR Bio’s primary industry is Drug Delivery.
-
Is AMR Bio a private or public company?
AMR Bio is a Private company.
-
What is AMR Bio’s current revenue?
The current revenue for AMR Bio is .
-
How much funding has AMR Bio raised over time?
AMR Bio has raised $979K.
-
Who are AMR Bio’s investors?
EMV Capital has invested in AMR Bio.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process